Lifecore Biomedical, Inc. De Income Statement

1Y3Y5Y7Y10YAll
Download Data
Income Statement May2009 May2010 May2011 May2012 May2013 May2014 May2015 May2016 May2017 May2018 May2019 May2020 May2021 May2022 May2023 May2024 May2025
Revenue & cost
Revenue 224.40M238.22M276.73M317.55M441.71M476.81M539.26M476.92M469.78M524.23M557.56M160.07M100.87M111.27M103.27M128.26M128.87M
Cost of Revenue 195.18M204.46M230.03M265.41M378.95M414.25M473.85M410.14M390.56M445.89M476.56M120.68M61.94M72.20M75.28M86.41M88.57M
Gross Profit 34.28M33.77M46.70M52.14M62.76M62.56M65.41M66.78M79.21M78.34M81.00M39.39M38.94M39.07M27.98M41.85M40.30M
Operating items
Research & Development 3.67M4.36M9.28M9.62M9.29M7.20M6.99M7.23M9.47M12.80M11.47M7.58M6.68M7.84M8.74M8.57M8.26M
Selling, General & Administrative 18.02M17.70M24.61M26.52M32.53M35.17M39.96M46.18M52.49M51.95M62.06M40.67M27.72M34.66M38.97M40.46M44.05M
Restructuring Costs 4.05M13.36M8.36M4.18M1.66M-1.75M
Other Operating Expenses 3.73M4.78M1.42M-3.93M34.00M-2.58M2.00M12.95M-2.11M39.50M0.41M
Operating Expenses 21.68M25.78M38.66M37.56M37.89M42.37M46.95M87.41M64.54M64.75M75.53M65.26M47.76M50.86M49.78M50.69M50.56M
Operating Income 12.60M7.98M8.03M14.58M24.87M20.19M18.46M-20.63M14.67M13.59M5.47M-25.88M-8.82M-11.79M-21.80M-8.84M-17.25M
EBIT 12.60M7.98M8.03M14.58M24.87M20.19M18.46M-20.63M14.67M13.59M5.47M-25.88M-8.82M-11.79M-21.80M-8.84M-17.25M
Non-operating items
Interest & Investment Income 1.31M0.83M0.43M1.12M1.12M1.12M1.42M1.65M1.65M1.65M1.65M0.07M0.05M0.08M0.07M-18.09M-21.84M
Other Non Operating Income 0.47M5.33M8.10M10.00M3.11M1.20M-1.23M2.90M1.60M-0.20M-10.97M0.76M-23.74M-3.05M-0.00M
Non Operating Income 3.73M0.47M5.33M8.10M10.00M3.11M1.20M0.90M2.90M1.60M-0.20M-10.97M0.76M-1.16M-3.05M-0.00M
Net income details
EBT 13.90M8.73M8.44M20.28M32.26M19.66M21.47M-19.69M14.18M16.40M3.64M-30.64M-29.79M-20.69M-63.93M9.51M-38.67M
Tax Provisions -5.61M-4.26M4.18M7.18M9.45M7.75M-7.70M4.04M-9.36M1.52M-8.77M-6.35M-5.21M0.31M0.18M0.04M
Profit After Tax 8.29M4.47M4.26M13.10M22.81M19.34M13.72M-11.99M10.68M25.76M2.12M-38.19M-32.29M-116.72M-99.56M12.01M-38.72M
Net Income - Minority -1.79M
Income from Non-Controlling Interests 0.48M0.34M0.40M0.23M0.20M0.18M0.19M0.09M0.09M
Income from Continuing Operations 19.51M12.99M4.26M13.10M22.81M19.66M13.72M-11.99M10.13M25.76M2.12M-21.87M-23.44M-15.48M-64.24M9.33M-38.72M
Consolidated Net Income 19.51M12.99M4.26M13.10M22.81M19.66M13.72M0.84M0.84M-1.19M-2.24M-20.66M-10.29M-101.93M-35.33M2.68M-38.72M
Income towards Parent Company 17.72M12.99M4.26M13.10M22.81M19.66M13.72M0.84M0.84M-1.19M-2.24M-20.66M-10.29M-101.93M-35.33M2.68M-38.72M
Preferred Dividend Payments 3.32M
Net Income towards Common Stockholders 17.72M12.99M4.26M13.10M22.81M19.66M13.72M0.84M0.84M-1.19M-2.24M-20.66M-10.29M-101.93M-35.33M12.01M-44.36M
Additional items
EPS (Basic) 0.680.150.150.490.870.720.50-0.450.390.930.07-1.31-1.10-3.97-3.320.39-1.27
EPS (Weighted Average and Diluted) 662.290.150.150.490.850.710.50-0.450.380.920.07-1.31-1.10-3.97-3.320.33-1.27
Shares Outstanding (Weighted Average) 26.24M26.41M26.39M25.55M25.93M26.78M26.95M27.07M27.31M27.56M29.18M29.18M29.33M29.48M30.32M30.55M37.03M
Shares Outstanding (Diluted Average) 0.03M0.03M0.03M26.13M0.03M0.03M27.34M27.04M27.65M27.91M28.61M29.16M29.29M29.47M29.96M36.66M34.82M
EBITDA 7.73M3.98M3.92M12.70M22.59M19.14M13.54M-11.64M11.02M13.59M5.47M-25.88M-8.82M-11.79M-21.80M-8.84M-17.25M
Interest Expenses -0.01M0.09M0.82M0.93M2.01M1.65M1.83M1.99M1.83M1.95M5.23M4.65M8.93M15.47M17.23M14.66M
Tax Rate 49.53%35.42%29.30%36.08%39.12%28.50%41.70%28.63%21.32%25.19%1.92%